Back

Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Clinical questions: management of patients with atrial fibrillation Rate Control ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Laurent Fauchier

University Hospital of Tours, Tours (France)

4 More presentations in this session

Presentation thumbnail
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation: A nationwide cohort study
Doctor T. Chao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Risk of atrial fibrillation development of sodium-glucose co-transporter 2 inhibitor and thiazolidinedione treatment among patients with type 2 diabetes
Assistant Professor Y. Kim (Gwangju, KR)
Abstract Slides Video
Presentation thumbnail
Oral anticoagulation in atrial fibrillation patients at intermediate risk of stroke: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)
Doctor M. Anjum (Baerum, NO)
Abstract Slides Video
Presentation thumbnail
Low incidence of major complications after the first six hours post-atrial fibrillation ablation - same-day discharge safe and feasible in most patients
Doctor A. Paul Nordin (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical questions: management of patients with atrial fibrillation

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
A call for timely rhythm control strategy
thumbnail
Webinar
Making better decisions on rhythm control for AF to improve patient symptoms and morbidity
thumbnail
Congress Presentation
Medical treatment of atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources